Live feed
Filing
SC 13G
SC 13G0000902219-18-000412·Audentes Therapeutics, Inc.
Schedule 13G ownership disclosure
Audentes Therapeutics, Inc.
Security class unavailable · CUSIP: 05070R104
Event date: 2018-01-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,850,015
- Percent of class
- 10.8500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-18-000412
- Form type
- SC 13G
- Filer
- Audentes Therapeutics, Inc.
- CIK
- CIK 1628738
- Filed
- Feb 12, 2018
- Reporting period
- Jan 31, 2018
- Description
- Schedule 13G beneficial ownership